Drug class
Copper replacement agent; copper–histidine complex for parenteral supplementation
Mechanism of action
Provides bioavailable copper for cellular copper-dependent enzyme systems. Copper is required for normal activity of cytochrome c oxidase, lysyl oxidase, dopamine beta-hydroxylase and other cuproenzymes; replacement addresses systemic copper deficiency due to impaired transport.
General use cases
- Treatment of paediatric patients with Menkes disease, including presymptomatic and symptomatic infants, under the product-specific copper histidinate indication; early initiation is important and use is specialist-directed
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
